|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/05 | |
| A61K 31/232 | |||
| A61K 31/7024 | |||
| A61P 9/00 | |||
| A61P 9/14 |
| (11) | Number of the document | 2830602 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13712624.9 |
| Date of filing the European patent application | 2013-03-11 | |
| (97) | Date of publication of the European application | 2015-02-04 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/030211 |
| Date | 2013-03-11 |
| (87) | Number | WO 2013/148136 |
| Date | 2013-10-03 |
| (30) | Number | Date | Country code |
| 201261618161 P | 2012-03-30 | US |
| (72) |
SANCILIO, Frederick, US
PERSICANER, Peter, US
CACACE, Janice, US
DAHIM, Mohand, US
|
| (73) |
Omega Biopharma, Inc. ,
345 Hill Avenue, Nashville, TN 37210,
US
|
| (54) | OMEGA-3 FATTY ACID ESTER COMPOSITIONS |
| OMEGA-3 FATTY ACID ESTER COMPOSITIONS |